Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence
about
Pathogenesis of human immunodeficiency virus infectionInduction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer elementEpstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancerInactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophagesInhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cellsCooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1.Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequenceThe Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1.The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses.Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression.Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirusRas-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in traActivation of the cellular transcription factor AP-1 in herpes simplex virus infected cells is dependent on the viral immediate-early protein ICPO.Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?
P2860
Q24634681-0FA6A63E-D48D-4A06-B1E2-A22CA80F4FE6Q28323598-AD7E119B-CE94-47ED-B68C-8D9F094731F9Q30452167-2FB6F5F0-6CA4-4EAB-A7C3-931BA0F2A9CEQ33581303-52EC541F-52AD-4E30-B6C1-63F944793A2EQ33919346-82E05233-C5BF-4F94-BD18-DE35C0B64EF6Q34295016-000BF9C7-B49E-4CD3-93B6-577D82B9F9AFQ34473624-E27007C4-0695-4318-B23B-764117C79E38Q35600426-4E9BD6C3-ED13-4702-BBB3-25A39FE38AD1Q35828854-1DABAF22-DB8C-4070-905C-2C88591AF942Q35870516-511862D5-37F5-4D4D-A26A-C0AF3D5CD6A4Q36628240-D8B9EED6-C4F4-476A-B50B-371DCCBAB349Q36642257-89EE6E07-8B53-4DAD-A6BD-C664A7AD2C83Q36682395-F098A132-48AA-41D5-835C-76555F3210F4Q36698102-2CA743E2-8C33-45F1-84F7-B5F79BD899BAQ36804236-2C067101-DA78-46D1-84F7-5D928AF31640Q36807977-DDAF1EB8-8B63-45EC-A478-13F7E652BFEFQ36831819-95F349AD-15C7-4AB6-B13D-C06F7344DCBFQ37552271-20A2E535-8D06-413A-8200-4B6BB4120B08Q37572418-C36D0768-A5AD-4ACB-971D-D80A9FDDE604Q37611462-9031EE0E-6634-48CB-9FFA-546D32417C1EQ39585343-7580183F-1597-4D5C-9EE0-A16B313F3DA7Q39595937-22456020-FE30-4AF3-A20C-BDC3BBFE68A4Q40039602-793B61EF-2B5F-497A-A2E9-FFA9C3B9CF05Q40064469-53BF4351-61AB-4CE9-AEA2-F7A11DC75EF4Q40506927-8E4CC989-0CE8-4EAC-8114-BFD456020896Q55397851-7F8C4109-C522-44E4-9D6D-59F45359779E
P2860
Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Activation of the human immuno ...... kappa B/core enhancer sequence
@en
type
label
Activation of the human immuno ...... kappa B/core enhancer sequence
@en
prefLabel
Activation of the human immuno ...... kappa B/core enhancer sequence
@en
P2093
P2860
P1433
P1476
Activation of the human immuno ...... kappa B/core enhancer sequence
@en
P2093
P2860
P304
P407
P577
1988-11-01T00:00:00Z